Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | KIF11 | P52732 | 7/20 | 0.47 |
| ▸ | GABRP | O00591 | 2/20 | 0.46 |
| ▸ | GABRD | O14764 | 2/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.46 |
| ▸ | GABRE | P78334 | 2/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8026806 | 0.83 | KDM4E (0.50) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL4892845 | 0.82 | PARP1 (0.44) | MAPTMAPK1NPSR1KIF11ALDH1A1 | |
| SCHEMBL9514812 | 0.81 | MAPT (0.53) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL9653404 | 0.80 | KIF11 (0.47) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL3462093 | 0.79 | KIF11 (0.53) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL28041995 | 0.77 | MAPT (0.59) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL67665 | 0.77 | KIF11 (0.55) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL6265148 | 0.77 | GABRP (0.46) | MAPTKIF11GABRPGABRDGABRA1 | |
| SCHEMBL9644913 | 0.77 | MAPT (0.55) | MAPTMAPK1NPSR1KIF11GABRP | |
| SCHEMBL2139000 | 0.76 | KIF11 (0.44) | MAPTMAPK1NPSR1KIF11GABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090282902-A1 | BIO SURFACE ACOUSTIC WAVE (SAW) RESONATOR AMPLIFICATION FOR DETECTION OF A TARGET ANALYTE | ATONOMICS A/S (DK) | 2009-11-19 | — | — | US | claimed |
| US-20090191573-A1 | METHOD AND KIT FOR DETERMINING ANTIGEN CONTENT IN A SAMPLE USING DOUBLE IMMUNOHISTOCHEMICAL DETECTION | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2009-07-30 | — | — | US | claimed |
| EP-2059814-A1 | METHOD AND KIT FOR DETERMINING ANTIGEN CONTENT IN A SAMPLE USING DOUBLE IMMUNOHISTOCHEMICAL DETECTION | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2009-05-20 | — | — | EP | claimed |
| EP-2057461-A2 | BIO SURFACE ACOUSTIC WAVE (SAW) RESONATOR AMPLIFICATION FOR DETECTION OF A TARGET ANALYTE | Atonomics A/S (DK) | 2009-05-13 | — | — | EP | claimed |
| WO-2008023055-A1 | METHOD AND KIT FOR DETERMINING ANTIGEN CONTENT IN A SAMPLE USING DOUBLE IMMUNOHISTOCHEMICAL DETECTION | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2008-02-28 | — | — | WO | claimed |
| WO-2008019693-A2 | BIO SURFACE ACOUSTIC WAVE (SAW) RESONATOR AMPLIFICATION FOR DETECTION OF A TARGET ANALYTE | ATONOMICS A/S (DK) | 2008-02-21 | — | — | WO | claimed |
| EP-1023604-A4 | METHOD FOR LOCALIZATION AND QUANTITATION OF A SUBSTANCE IN A BIOLOGICAL SAMPLE | UNIV WASHINGTON (US) | 2001-05-30 | — | — | EP | claimed |
| EP-1023604-A1 | METHOD FOR LOCALIZATION AND QUANTITATION OF A SUBSTANCE IN A BIOLOGICAL SAMPLE | WASHINGTON UNIVERSITY (US) | 2000-08-02 | — | — | EP | claimed |
| US-5902727-A | SIMPLE AND EFFICIENT ANALYSIS BY BINDING ENZYME LINKED PROBE TO TARGET, ADDING SUBSTRATE(S), DETECTING INSOLUBLE AND SOLUBLE PRODUCTS | WASHINGTON UNIVERSITY (US) | 1999-05-11 | — | — | US | claimed |
| WO-1998010290-A1 | METHOD FOR LOCALIZATION AND QUANTITATION OF A SUBSTANCE IN A BIOLOGICAL SAMPLE | WASHINGTON UNIVERSITY (US) | 1998-03-12 | — | — | WO | claimed |
| US-20260109783-A1 | ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE | MESOBLAST, INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-12589150-B2 | Antibodies binding AXL | GENMAB A/S (DK) | 2026-03-31 | — | — | US | disclosed |
| US-20260051055-A1 | DOMAIN SWAP AND ARTIFICIAL GENERATED VIRTUAL IMAGES | VENTANA MEDICAL SYSTEMS, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-12275801-B2 | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase | MESOBLAST, INC. (US) | 2025-04-15 | — | — | US | disclosed |
| EP-3402822-B1 | AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT | GENMAB AS (DK) | 2025-03-12 | — | — | EP | disclosed |
| EP-0197974-A1 | ACINO-FOETAL DIFFERENTIATION PROTEINS ASSOCIATED TO THE PANCREAS CANCER, ANTISERUM AND MONOCLONAL ANTIBODIES TO SAID PROTEINS, PREPARATION METHODS | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-10-22 | — | — | EP | disclosed |
| EP-0196743-A2 | Stable chemical compositions containing chromogenic materials and peroxides, and method for obtaining them | SAVYON DIAGNOSTICS LTD. (IL) | 1986-10-08 | — | — | EP | disclosed |
| EP-0180496-A1 | Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-05-07 | — | — | EP | disclosed |
| WO-1986002081-A1 | ACINO-FOETAL DIFFERENTIATION PROTEINS ASSOCIATED TO THE PANCREAS CANCER, ANTISERUM AND MONOCLONAL ANTIBODIES TO SAID PROTEINS, PREPARATION METHODS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 1986-04-10 | — | — | WO | disclosed |
| EP-0118365-A2 | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy | HEALTH RESEARCH, INC. (US) | 1984-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589150-B2 | Antibodies binding AXL | IGSF11, FLT1, VSIG8 | MAPT 3294/4885MAPK1 1670/4885NPSR1 486/4885 |
| US-20260109783-A1 | ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE | ALPP, S100P, ALPG | MAPT 2097/4885MAPK1 3337/4885NPSR1 1893/4885 |
| US-20260051055-A1 | DOMAIN SWAP AND ARTIFICIAL GENERATED VIRTUAL IMAGES | DSG1, DSP, CCND1 | MAPT 1007/4885MAPK1 3763/4885NPSR1 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.